세계의 코센틱스(Cosentyx) 의약품 시장 보고서(2025년) : 역학, 파이프라인 분석, 시장 인사이트 및 예측

Cosentyx Drug Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

US $ 4,490 ￦ 6,310,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,121,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,932,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

코센틱스 의약품 시장은 향후 몇 년 동안 강력한 성장을 보일 것으로 예상됩니다. 예측 기간 동안의 성장은 자가 면역 질환의 유병률 증가, 승인된 적응증의 확대, 생물학적 치료법의 발전, 유리한 보험 적용 정책, 강력한 임상 결과 등에 기인할 수 있습니다. 예측 기간의 주요 트렌드로는 자가 면역 질환에 대한 적용 확대, 맞춤형 의약품으로의 전환, 피하 투여 및 새로운 치료 분야의 R&D의 지배력 강화 등이 있습니다.

자가 면역 질환의 유병률 증가는 코센틱스 시장의 성장을 촉진할 것으로 예상됩니다. 자가 면역 질환은 면역 체계가 신체의 건강한 세포와 조직을 잘못 공격할 때 발생합니다. 이러한 증가는 유전적 소인, 환경적 영향(감염 및 오염 물질 등) 및 스트레스 수준 증가 및 식습관 변화와 같은 생활 방식의 변화와 같은 요인에 기인할 수 있습니다. 코센틱스는 염증 과정에 관여하는 사이토카인인 인터루킨-17A를 표적으로 억제하여 자가 면역 질환 치료에 중요한 역할을 합니다. 이는 증상을 완화하고, 삶의 질을 개선하며, 건선, 건선성 관절염, 강직성 척추염과 같은 질환을 효과적으로 관리하는 데 도움이 됩니다. 예를 들어, 2023년 7월, 스코틀랜드 공중보건국은 2022년에 새로 진단된 다발성 경화증(MS) 환자 수가 87.2% 증가했다고 보고하며, 자가면역질환의 유병률이 증가하고 있으며 코센틱스와 같은 치료제에 대한 수요가 촉진되고 있다고 강조했습니다.

의료비 지출의 증가는 코센틱스 시장을 견인할 것으로 예상됩니다. 고령화, 만성 질환, 첨단 의료 기술, 의약품 가격 상승에 따른 의료 서비스에 대한 지출 증가로 코센틱스와 같은 생물학적 제제에 대한 투자가 증가했습니다. 이 생물학적 제제는 특히 중등도 내지 중증의 건선, 건선성 관절염, 강직성 척추염의 관리에 사용되며, 표적 치료를 통해 환자의 치료 결과를 개선합니다. 2024년 5월 영국 국가통계청(ONS)은 2022년부터 2023년까지 총 의료 지출이 5.6% 증가했다고 보고했으며, 이는 의료 및 생물학적 치료에 대한 재정적 투자가 증가하고 있음을 다시 한 번 강조했습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 바이오의약품 시장에서의 제품 특성

• 분자 유형
• 투여경로(ROA)
• 작용기전(MOA)
• 안전성과 유효성

제4장 시장 동향과 전략

제5장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 경기 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제6장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 코센틱스 의약품 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 코센틱스 의약품 시장 : 성장률 분석
• 세계의 코센틱스 의약품 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 코센틱스 의약품 시장 예측 : 규모와 성장(2024-2029년, 2034년)
• 세계의 코센틱스 의약품 : 전체 시장 규모(TAM)

제7장 세계 시장의 가격 분석과 예측

제8장 시장 세분화

• 세계의 코센틱스 의약품 시장 : 적응증별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 화농성 땀샘염
• 건선성 관절염
• 강직성 척추염
• 건선
• 세계의 코센틱스 의약품 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 피하 주사
• 정맥내 주입
• 세계의 코센틱스 의약품 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 병원 약국
• 온라인 약국
• 소매 약국

제9장 임상적응증 세계 시장 역학

• 약제의 부작용
• 임상적응증의 발병률과 유병률

제10장 지역별, 국가별 분석

• 세계의 코센틱스 의약품 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 코센틱스 의약품 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 한국 시장

제17장 서유럽 시장

제18장 영국 시장

제19장 독일 시장

제20장 프랑스 시장

제21장 동유럽 시장

제22장 북미 시장

제23장 미국 시장

제24장 캐나다 시장

제25장 남미 시장

제26장 중동 시장

제27장 아프리카 시장

제28장 경쟁 구도와 기업 프로파일

• 코센틱스 의약품 시장 : 경쟁 구도
• 코센틱스 의약품 시장 : 기업 프로파일
  • Novartis AG
  • Sandoz
  • D. Vijay Pharma Private Limited
  • KinBio
  • Zymeth Pharmaceuticals Private Limited

제29장 세계 시장 : 파이프라인 분석

제30장 세계 시장 경쟁 벤치마킹과 대시보드

제31장 주요 인수합병(M&A)

제32장 최근 시장 동향

제33장 시장의 잠재력이 높은 국가, 전략

• 코센틱스 의약품 시장(2029년) : 새로운 기회를 제공하는 국가
• 코센틱스 의약품 시장(2029년) : 새로운 기회를 제공하는 부문
• 코센틱스 의약품 시장(2029년) : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제34장 부록

HBR

영문 목차

영문목차

Cosentyx (secukinumab) is a prescription biologic medication developed by Novartis. It is a monoclonal antibody that targets interleukin-17A (IL-17A), a protein involved in inflammation. Cosentyx is primarily used to treat autoimmune conditions such as plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Administered via subcutaneous injection, it helps reduce inflammation, alleviate skin symptoms, and prevent joint damage. The drug has demonstrated effectiveness in improving the quality of life for patients suffering from these chronic conditions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary indications for cosentyx include hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. Hidradenitis suppurativa is a chronic skin condition that causes painful lumps, abscesses, and scarring, typically in areas with sweat glands such as the underarms and groin. The routes of administration include subcutaneous injection and intravenous infusion, with distribution channels encompassing hospital pharmacies, online pharmacies, and retail pharmacies.

The cosentyx drug market research report is one of a series of new reports from The Business Research Company that provides cosentyx drug market statistics, including cosentyx drug industry global market size, regional shares, competitors with a cosentyx drug market share, detailed cosentyx drug market segments, market trends and opportunities, and any further data you may need to thrive in the cosentyx drug industry. This cosentyx drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cosentyx drug market size is expected to see strong growth in the next few years. It will grow to $8,030.8 million in 2029 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to the increasing prevalence of autoimmune diseases, expansion of approved indications, advancements in biologic therapies, favorable reimbursement policies, and strong clinical outcomes. Major trends in the forecast period include expanding applications for autoimmune diseases, shifting toward personalized medicine, and the dominance of subcutaneous administration and R&D in new therapeutic areas.

The increasing prevalence of autoimmune diseases is expected to drive the growth of the cosentyx market. Autoimmune diseases occur when the immune system mistakenly attacks the body's healthy cells and tissues. This rise can be attributed to factors such as genetic predisposition, environmental influences (e.g., infections and pollutants), and lifestyle changes, including higher stress levels and dietary shifts. Cosentyx (secukinumab) plays a vital role in treating autoimmune conditions by targeting and inhibiting interleukin-17A, a cytokine involved in the inflammatory process. This helps reduce symptoms, improve the quality of life, and manage conditions like psoriasis, psoriatic arthritis, and ankylosing spondylitis effectively. For example, in July 2023, Public Health Scotland reported that the number of newly diagnosed multiple sclerosis (MS) patients increased by 87.2% in 2022, highlighting the growing prevalence of autoimmune diseases and driving demand for treatments like cosentyx.

Rising healthcare expenditure is expected to propel the cosentyx market. Increased spending on healthcare services, driven by an aging population, chronic diseases, advanced medical technology, and higher drug prices, has led to more investment in biologic therapies like Cosentyx. The biologic drug is especially used in managing moderate to severe psoriasis, psoriatic arthritis, and ankylosing spondylitis, improving patient outcomes through targeted therapy. In May 2024, the UK's Office for National Statistics reported a 5.6% rise in total healthcare expenditure from 2022 to 2023, further highlighting the increasing financial commitment to healthcare and biologic treatments.

A key trend in the cosentyx market is the development of advanced biological therapies to address unmet medical needs and improve treatment efficacy. Cosentyx is part of this trend, with a focus on managing chronic autoimmune conditions using targeted therapies. For instance, in October 2023, Novartis AG, a Switzerland-based pharmaceutical company, received FDA approval for Cosentyx as the first new biologic treatment option for moderate to severe hidradenitis suppurativa (HS) in nearly a decade. This approval represents a significant advancement in HS treatment, demonstrating Cosentyx's growing role in autoimmune disease management and expanding its market reach.

Key player operating in the cosentyx drug market is Novartis AG

North America was the largest region in the cosentyx drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cosentyx drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cosentyx drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cosentyx drug market consists of sales oflyophilized powder, and self-administered autoinjector. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cosentyx Drug Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cosentyx drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cosentyx drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cosentyx drug market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Indication: Hidradenitis suppurativa; Psoriatic arthritis; Ankylosing spondylitis; Plaque Psoriasis
• 2) By Route Of Administration: Subcutaneous injection; Intravenous infusion
• 3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies
• Companies Mentioned: Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cosentyx Drug Market Characteristics

3. Cosentyx Drug Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Cosentyx Drug Market Trends And Strategies

5. Cosentyx Drug Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Cosentyx Drug Growth Analysis And Strategic Analysis Framework

• 6.1. Global Cosentyx Drug PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Cosentyx Drug Market Growth Rate Analysis
• 6.4. Global Cosentyx Drug Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Cosentyx Drug Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Cosentyx Drug Total Addressable Market (TAM)

7. Global Cosentyx Drug Market Pricing Analysis & Forecasts

8. Cosentyx Drug Market Segmentation

• 8.1. Global Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hidradenitis suppurativa
• Psoriatic arthritis
• Ankylosing spondylitis
• Plaque Psoriasis
• 8.2. Global Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Subcutaneous injection
• Intravenous infusion
• 8.3. Global Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

9. Global Cosentyx Drug Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Cosentyx Drug Market Regional And Country Analysis

• 10.1. Global Cosentyx Drug Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Cosentyx Drug Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Cosentyx Drug Market

• 11.1. Asia-Pacific Cosentyx Drug Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Cosentyx Drug Market

• 12.1. China Cosentyx Drug Market Overview
• 12.2. China Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Cosentyx Drug Market

• 13.1. India Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Cosentyx Drug Market

• 14.1. Japan Cosentyx Drug Market Overview
• 14.2. Japan Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Cosentyx Drug Market

• 15.1. Australia Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Cosentyx Drug Market

• 16.1. South Korea Cosentyx Drug Market Overview
• 16.2. South Korea Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Cosentyx Drug Market

• 17.1. Western Europe Cosentyx Drug Market Overview
• 17.2. Western Europe Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Cosentyx Drug Market

• 18.1. UK Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Cosentyx Drug Market

• 19.1. Germany Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Cosentyx Drug Market

• 20.1. France Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cosentyx Drug Market

• 21.1. Eastern Europe Cosentyx Drug Market Overview
• 21.2. Eastern Europe Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Cosentyx Drug Market

• 22.1. North America Cosentyx Drug Market Overview
• 22.2. North America Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Cosentyx Drug Market

• 23.1. USA Cosentyx Drug Market Overview
• 23.2. USA Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Cosentyx Drug Market

• 24.1. Canada Cosentyx Drug Market Overview
• 24.2. Canada Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Cosentyx Drug Market

• 25.1. South America Cosentyx Drug Market Overview
• 25.2. South America Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Cosentyx Drug Market

• 26.1. Middle East Cosentyx Drug Market Overview
• 26.2. Middle East Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Cosentyx Drug Market

• 27.1. Africa Cosentyx Drug Market Overview
• 27.2. Africa Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Cosentyx Drug Market Competitive Landscape And Company Profiles

• 28.1. Cosentyx Drug Market Competitive Landscape
• 28.2. Cosentyx Drug Market Company Profiles
  • 28.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.2. Sandoz Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.3. D. Vijay Pharma Private Limited Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.4. KinBio Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.5. Zymeth Pharmaceuticals Private Limited Overview, Products and Services, Strategy and Financial Analysis

29. Global Cosentyx Drug Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Cosentyx Drug Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Cosentyx Drug Market

32. Recent Developments In The Cosentyx Drug Market

33. Cosentyx Drug Market High Potential Countries, Segments and Strategies

• 33.1 Cosentyx Drug Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Cosentyx Drug Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Cosentyx Drug Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer

관련자료